According to Relay Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.58. In 2022 the company made an earnings per share (EPS) of -$4.10 an increase over its 2021 EPS that were of -$6.06.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$4.37 | 6.82% |
2022 | -$4.10 | -32.47% |
2021 | -$6.06 | -57.09% |
2020 | -$14.13 | -36.27% |
2019 | -$22.18 |